MedTrace Logo

Phase IV Study On Muscle Activity Of Two Commercial Preparations Of Botulinum

NCT01728337 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-07-26

Study results available
· View outcomes & findings →

Summary

this study was proposed to provide more scientific and objective data on the clinical and aesthetic effects of these two toxins (Dysport and Xeomin).

Conditions

  • Sun-induced Wrinkles

Interventions

DRUG

Dysport

Dysport® was injected on the right side of the forehead and Xeomin® was injected on the left side of the forehead.

DRUG

Xeomin

Xeomin® was injected on the right side of the forehead and Dysport® was injected on the left side of the forehead

Sponsors & Collaborators

  • Brazilan Center for Studies in Dermatology

    lead OTHER

Principal Investigators

  • Doris Hexsel, MD · Brazilian Center for Dermatologic Studies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01728337 on ClinicalTrials.gov